Quick Answer
AVITA Medical, Inc. reported Common Stock Shares Outstanding of 30.57 million shares for the year ending 2025.
- AVITA Medical, Inc. showed an increase of +16.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 21.62 million shares | Q4 2020: 21.63 million shares | Q1 2021: 24.84 million shares | Q3 2021: 24.93 million shares | Q1 2022: 24.96 million shares | Q2 2022: 25.00 million shares | Q3 2022: 25.03 million shares | Q1 2023: 25.33 million shares | Q2 2023: 25.45 million shares | Q3 2023: 25.55 million shares | Q1 2024: 25.79 million shares | Q2 2024: 25.95 million shares | Q3 2024: 26.22 million shares | Q1 2025: 26.43 million shares | Q2 2025: 26.61 million shares | Q3 2025: 30.49 million shares.
- Over the full 8 years of available data (2019 to 2025), AVITA Medical, Inc.'s Common Stock Shares Outstanding has grown by 63.4%.
- Historical annual values: Fiscal year 2025: 30.57 million shares | Fiscal year 2024: 26.35 million shares | Fiscal year 2023: 25.68 million shares | Fiscal year 2022: 25.21 million shares | Fiscal year 2021: 24.93 million shares | Fiscal year 2021: 24.90 million shares | Fiscal year 2020: 21.47 million shares | Fiscal year 2019: 18.71 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: